A peptide enhancement strategy in Alzheimer's disease: pilot study with TRH-physostigmine infusions.
Mellow
A M
AM
Department of Psychiatry, University of Michigan Medical School, Ann Arbor.
Aronson
S M
SM
Giordani
B
B
Berent
S
S
D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D010455:Peptides / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology / Q000627:therapeutic use*; D010865:Pilot Projects; D013647:Task Performance and Analysis; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology* / Q000627:therapeutic use
D010455:Peptides; D013973:Thyrotropin-Releasing Hormone; D010830:Physostigmine